C4 Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MORGAN STANLEY | 05/15/2026 | 9.07 M | $23.86 M | 1.01% | 10.94% |
| RA CAPITAL MANAGEMENT, L.P. | 05/15/2026 | 8.00 M | $21.04 M | 0.00% | 9.65% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 05/15/2026 | 7.17 M | $18.86 M | 0.00% | 8.65% |
| LYNX1 CAPITAL MANAGEMENT LP | 05/04/2026 | 7.00 M | $18.41 M | -1.40% | 8.44% |
| 05/15/2026 | 3.86 M | $10.16 M | 100.00% | 4.66% | |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 05/14/2026 | 3.80 M | $10.00 M | 0.00% | 4.59% |
| JPMORGAN CHASE & CO | 05/13/2026 | 3.22 M | $7.57 M | 54,114.53% | 3.89% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 3.04 M | $7.98 M | 101.09% | 3.66% |
| WASATCH ADVISORS LP | 04/21/2026 | 2.96 M | $7.79 M | -31.83% | 3.57% |
| CITADEL ADVISORS LLC | 05/15/2026 | 2.51 M | $6.60 M | 460.73% | 3.03% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 2.46 M | $6.47 M | 53.62% | 2.97% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 2.39 M | $6.28 M | 119.22% | 2.88% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 2.36 M | $6.20 M | -1.19% | 2.85% |
| 05/15/2026 | 2.25 M | $5.92 M | 100.00% | 2.71% | |
| BLACKROCK, INC. | 05/13/2026 | 2.05 M | $5.39 M | 4.00% | 2.47% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 05/14/2026 | 1.91 M | $5.03 M | -4.13% | 2.31% |
| ACADIAN ASSET MANAGEMENT LLC | 05/13/2026 | 1.89 M | $4.97 M | 187.73% | 2.28% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 1.39 M | $3.66 M | 17.19% | 1.68% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 1.29 M | $3.38 M | -27.53% | 1.55% |
| JANE STREET GROUP, LLC | 05/12/2026 | 1.25 M | $3.28 M | 42.54% | 1.50% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 1.06 M | $2.79 M | 1,905.20% | 1.28% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 951.04 K | $2.50 M | -3.83% | 1.15% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 867.91 K | $2.28 M | 7.25% | 1.05% |
| ORBIMED ADVISORS LLC | 05/15/2026 | 856.35 K | $2.25 M | -39.05% | 1.03% |
| CONGRESS ASSET MANAGEMENT CO /MA | 04/14/2026 | 830.62 K | $2.18 M | 100.00% | 1.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2026 | 752.11 K | $1.98 M | 159.14% | 0.91% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 484.13 K | $1.27 M | 100.00% | 0.58% |
| STEMPOINT CAPITAL LP | 05/18/2026 | 453.24 K | $1.19 M | 100.00% | 0.55% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 452.23 K | $1.19 M | 0.62% | 0.55% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 442.52 K | $1.16 M | 49.26% | 0.53% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 05/14/2026 | 384.77 K | $1.01 M | 100.00% | 0.46% |
| STATE STREET CORP | 05/15/2026 | 382.97 K | $1.01 M | 11.73% | 0.46% |
| BARCLAYS PLC | 05/15/2026 | 317.88 K | $836.02 K | 45.01% | 0.38% |
| 683 CAPITAL MANAGEMENT, LLC | 05/15/2026 | 300.00 K | $789.00 K | -25.00% | 0.36% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 05/11/2026 | 277.18 K | $728.99 K | 634.82% | 0.33% |
| FMR LLC | 05/15/2026 | 272.37 K | $716.33 K | 7.06% | 0.33% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 05/15/2026 | 264.62 K | $695.95 K | 100.00% | 0.32% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 05/15/2026 | 260.28 K | $684.53 K | -4.33% | 0.31% |
| MAN GROUP PLC | 05/15/2026 | 256.47 K | $674.51 K | 64.30% | 0.31% |
| LPL FINANCIAL LLC | 05/06/2026 | 246.80 K | $649.08 K | 1.44% | 0.30% |
| INVESCO LTD. | 05/12/2026 | 244.51 K | $643.05 K | -8.89% | 0.30% |
| WALLEYE CAPITAL LLC | 05/13/2026 | 239.12 K | $628.88 K | -46.06% | 0.29% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 05/13/2026 | 223.17 K | $586.93 K | -5.89% | 0.27% |
| UBS GROUP AG | 05/05/2026 | 215.88 K | $567.76 K | 309.23% | 0.26% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 190.35 K | $500.62 K | 8,708.33% | 0.23% |
| NORTHERN TRUST CORP | 05/14/2026 | 189.48 K | $498.33 K | 14.00% | 0.23% |
| TORONTO DOMINION BANK | 05/15/2026 | 174.66 K | $459.36 K | 100.00% | 0.21% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 169.10 K | $444.72 K | -98.21% | 0.20% |
| HRT FINANCIAL LP | 05/14/2026 | 162.93 K | $428.00 K | 100.00% | 0.20% |
| MARSHALL WACE, LLP | 05/15/2026 | 155.50 K | $408.95 K | -41.33% | 0.19% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
C4 Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 144 institutional investors and hedge funds held shares of C4 Therapeutics Inc. The most heavily invested institutionals were:
MORGAN STANLEY: 9.07 M
RA CAPITAL MANAGEMENT, L.P.: 8 M
Bain Capital Life Sciences Investors, LLC: 7.17 M
Lynx1 Capital Management LP: 7 M
Soleus Capital Management, L.P.: 3.8 M
JPMORGAN CHASE & CO: 3.22 M
101.93% of C4 Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 89.56 M shares in the last 24 months. This purchase volume represents approximately $321.52 M in transactions.